Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/11/059428
CTRI/2023/11/059428
Not yet recruiting
Phase 3

An open clinical trial to evaluate the efficacy ofVatsakadi Vati in management of hyperlipidemia - NI

Vd Vaishali Shamrao Meshram0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: E785- Hyperlipidemia, unspecified

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Sponsor
Vd Vaishali Shamrao Meshram
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Vd Vaishali Shamrao Meshram

Eligibility Criteria

Inclusion Criteria

  • •1\.Patient irrespective of age, sex, religion etc.of Hyperlipidemia.
  • •2\.Patients with high blood lipid profile.Lipid profile showing any one or more of the following criteria was considered diagnostic of hyperlipidemia.
  • •3\.Patients with controlled Type 2 diabetes mellitus and hypertensive patients with blood pressure within the normal limits.
  • •4\.Obese Hyperlipidemic and Non\-Obese hyperlipidemic Patients (BMI\-18\.50 to 40\.00 kg/m2 as per New Updated WHO classification of BMI of 2004\).
  • •5\.Patient having Serum Total Cholesterol Level \>200mg/dl.
  • •6\.Patient having Serum LDL Cholesterol Level \>130mg/dl
  • •7\.Patient having serum VLDL Cholesterol Level \>40mg/dl.
  • •8\.Patient having Serum HDL Cholesterol Level \<40mg/dl.
  • •9\.Patient having Serum Triglyceride Level \>150mg/dl.

Exclusion Criteria

  • •1\.Patients having a history of untreated thyroid disorder.
  • •2\.Pregnant women \& lactating mother.
  • •3\.Chronic illness and infection like TB, CA and HIV infection.
  • •4\.Patient is suffering with psychological disorders like anxiety, depression.
  • •5\.Patient with Respiratory Diseases Complications, Coronary Heart Disease, Hepatic or Renal Disease etc.
  • •6\.Drug induced Hyperlipidemia.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
A Clinical investigation to Evaluate the Efficacy and Safety of antistress formulation in Managing Anxiety Disorder.Health Condition 1: F41- Other anxiety disorders
CTRI/2024/05/066782Pankajakasthuri Herbals India Pvt Ltd P
Not yet recruiting
Phase 1
A Clinical Trial for Enema treatment with Hapushadi Drug in the management of Sciatica.Health Condition 1: M470- Anterior spinal and vertebral artery compression syndromes
CTRI/2019/11/022037Parul Institute of Ayurved
Not yet recruiting
Phase 2
To evaluate the clinical efficacy of Kottai Karanthai Chooranam (Internal), Semparuthi Poo Ennai (External) and Yoga Therapy for the treatment of Kalanjaga Padai (Psoriasis)Health Condition 1: null- Patients Suffering from Psoriasis
CTRI/2018/05/013972illy Shekenah B
Not yet recruiting
Phase 3
A clinical trial to study the effect of Swarnakshiryadi yog in the management of HyperbilirubinaemiaHealth Condition 1: R17- Unspecified jaundice
CTRI/2024/06/069642R. A. Podar Govt. Ayurvedic college
Not yet recruiting
Phase 2
To evaluate the efficacy of Sarvanga vatha chooranam(Internal), Mukkutu Yennai(External) for the treatment of Santhuvatham(Polyarthritis)
CTRI/2018/05/014186ivetha